Elara studie

Titel:  Phase II, single arm, multicenter open label trial to determine the efficacy and safety of tisagenlecleucel (CTL019) in adult patients with refractory or relapsed follicular lymphoma
- ≥ 2de lijn

maart 2020: De inclusie van de ELARA is gsloten

• Protocol (kwadraet)
• Inclusie criteria (kwadraet)
• Patienteninformatie

• Flowchart CRS/ICANS studie

Studie coordinator: Roberto Liu